Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer

Antibodies targeting the receptor programmed death 1 on T cells have been approved for the treatment of lung cancer. Immune checkpoint inhibitors (ICIs) induce various immune-related adverse events. Life-threatening hematotoxicity can be provoked by ICI therapy. Although ICI-related endocrinopathy a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Med Case Rep
Main Authors: Mori, Hidenori, Sakai, Chizuru, Iwai, Masamichi, Sasaki, Yuka, Gomyo, Takenobu, Toyoshi, Sayaka, Kaito, Daizo, Yanase, Komei, Ito, Fumitaka, Endo, Junki, Funaguchi, Norihiko, Ohno, Yasushi, Minatoguchi, Shinya
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6557745/
https://ncbi.nlm.nih.gov/pubmed/31198679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2019.100871
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados